Integrating artificial intelligence and other emerging technologies has become a strategic imperative for companies aiming to expand their product offerings and remain competitive. Product development and legal teams must carefully navigate legal and regulatory challenges when planning and developing an AI tool to avoid common pitfalls. To seamlessly and effectively implement AI and other emerging technologies in products and internal company tools, company leaders must proactively manage risk by focusing on three common overarching principles.

Read more in “Managing Legal Risks in AI Implementation” written by Greenberg Traurig Shareholder Chinh H. Pham and Associate Samuel S. Stone.

Print:
Email this postTweet this postLike this postShare this post on LinkedIn
Photo of Chinh H. Pham Chinh H. Pham

Chinh H. Pham is Co-Chair of the Venture Capital & Emerging Technology Practice at Greenberg Traurig and is an intellectual property attorney with experience in the strategic creation, implementation and protection of IP rights for technology and life science clients, including those in

Chinh H. Pham is Co-Chair of the Venture Capital & Emerging Technology Practice at Greenberg Traurig and is an intellectual property attorney with experience in the strategic creation, implementation and protection of IP rights for technology and life science clients, including those in the areas of software, artificial intelligence, virtual and augmented reality, blockchain, video gaming, nanotechnologies, medical devices, electro-mechanical devices, telecommunications, data mining, and electronic commerce. He can be reached at chinh.pham@gtlaw.com.

Photo of Samuel S. Stone Samuel S. Stone

Sam Stone focuses his practice on creating and implementing strategies to develop and enforce intellectual property portfolios. His patent counseling and portfolio development practice includes both domestic and international patents and opinion work on the topics of patentability, clearance, validity, and infringement. Sam’s…

Sam Stone focuses his practice on creating and implementing strategies to develop and enforce intellectual property portfolios. His patent counseling and portfolio development practice includes both domestic and international patents and opinion work on the topics of patentability, clearance, validity, and infringement. Sam’s patents have survived dozens of PTAB invalidity challenges, and have been licensed by some of the largest software and technology companies in the world. Sam also assists clients with IP due diligence in investment transactions, mergers and acquisitions, and initial public offerings (IPOs).

Sam counsels software and electronics companies operating in many industries, including autonomous vehicles and industrial automation, automated machine learning (AutoML), cybersecurity, biosensors, and high-performance computing. In addition, Sam advises technology and life science companies on strategies for protecting their investments in data science, artificial intelligence (AI), and machine learning (ML) in domains such as drug discovery, medical devices, medical imaging, agricultural technology, biomanufacturing, biological systems modeling, and ‘omics’ technologies.